UBI集團訊息
聯亞集團董事長特助彭文君博士向社會大眾報告UBI /聯亞生技集團新冠肺炎研發進度
聯亞集團董事長特助彭文君博士向社會大眾報告UBI /聯亞生技集團新冠肺炎研發進度。
全部產業訊息
-
-
View More 
Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White House生醫新知Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White House
Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices -
View More 
Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White House生技產業訊息Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices | The White House
Remarks by President Trump at Signing of Executive Orders on Lowering Drug Prices -
View More 
UBI/聯亞集團高精準設計新冠肺炎(COVID-19) 疫苗UB-612將於今年第三季展開第一期人體臨床試驗，TFDA 與CDE已派員進行駐廠監製UBI集團訊息UBI/聯亞集團高精準設計新冠肺炎(COVID-19) 疫苗UB-612將於今年第三季展開第一期人體臨床試驗，TFDA 與CDE已派員進行駐廠監製
UB-612已列入醫藥品查驗中心（CDE）「COVID-19專案輔導計畫案件」，並於6月22日向台灣食品藥物管理署（TFDA）提出第一期人體臨床試驗申請 -
View More 
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine生醫新知News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
As they race to devise a vaccine, researchers are trying to ensure that their candidates don’t spur a counterproductive, even dangerous, immune system reaction known as immune enhancement. -
View More 
News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine生技產業訊息News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
As they race to devise a vaccine, researchers are trying to ensure that their candidates don’t spur a counterproductive, even dangerous, immune system reaction known as immune enhancement. -
-
View More 
United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infectionUBI集團訊息United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
They have received Investigational New Drug (IND) approval from Taiwan FDA to conduct a Phase 3 clinical trial with UB-421 in patients with multi-drug resistant (MDR) HIV-1 infection. -
View More 
聯生藥抗體新藥UB-421用於多重抗藥性愛滋病患3期臨床試驗獲台灣FDA核准執行UBI集團訊息聯生藥抗體新藥UB-421用於多重抗藥性愛滋病患3期臨床試驗獲台灣FDA核准執行
UB-421應用於治療多重抗藥性(multi-drug resistant (MDR)HIV感染病患之3期臨床試驗已獲台灣FDA核准執行 -
View More 
Why coronavirus antibody testing in one Colorado town could provide a way forwardUBI集團訊息Why coronavirus antibody testing in one Colorado town could provide a way forward
Testing in the ski town Telluride could allow for fewer restrictions nationwide. -
View More 
「我們的任務是在這個非我所願的複雜混沌的時刻，展示自己最好的品格和行為。願我們與智慧和風度同行。」– Lawrence Bacow, President of Harvard UniversityUBI集團訊息「我們的任務是在這個非我所願的複雜混沌的時刻，展示自己最好的品格和行為。願我們與智慧和風度同行。」– Lawrence Bacow, President of Harvard University
UNITED BIOMEDICAL GROUP’S C19 COMPANY PARTNERS WITH SAN MIGUEL COUNTY, COLORADO TO BE FIRST IN NATION TO TEST AN ENTIRE COUNTY FOR COVID-19 WITH NEW ANTIBODY DIAGNOSTIC TEST -
View More 
Frequently asked questions about UBI SARS-CoV2 ELISAUBI集團訊息Frequently asked questions about UBI SARS-CoV2 ELISA
Frequently asked questions about UBI SARS-CoV2 ELISA
-
-
View More 
我們有話要說 (二)：病毒不斷突變也不怕！聯亞生技廣譜新冠疫苗可協助解決病毒變異及疫苗頻繁接種的安全與有效性！我們有話要說 (二)：病毒不斷突變也不怕！聯亞生技廣譜新冠疫苗可協助解決病毒變異及疫苗頻繁接種的安全與有效性！ -
View More 
我們有話要說 (三)：良好的保護力絕不能只看中和抗體！全球科學界大聲疾呼正視T細胞免疫記憶能力之重要性 –強力T細胞免疫才能提供免於感染各種變異病毒株的廣譜保護力–我們有話要說 (三)：良好的保護力絕不能只看中和抗體！全球科學界大聲疾呼正視T細胞免疫記憶能力之重要性 –強力T細胞免疫才能提供免於感染各種變異病毒株的廣譜保護力– -
View More 
我們有話要說(四)：聯亞生技UB-612新冠疫苗追加劑試驗數據展現強效且廣譜的的B細胞和T細胞免疫能力; 期盼政府支持UB-612加速審查，共同為國家與人民福祉創造多贏我們有話要說(四)：聯亞生技UB-612新冠疫苗追加劑試驗數據展現強效且廣譜的的B細胞和T細胞免疫能力; 期盼政府支持UB-612加速審查，共同為國家與人民福祉創造多贏
TAG相關標籤
POPULAR熱門文章
